Ashish Prasad is a Partner in the Litigation and Dispute Resolution practice of ELP and is based in Delhi. He earned his law degree from Delhi University in the year 2003 and has completed courses in Intellectual Property laws in addition to holding a Diploma on Cyber Laws. Ashish is admitted with Bar at Delhi.

Ashish has vast experience in handling commercial litigation and IP issues. Having started his career with Lall & Sethi Advocates in 2003, he has advised and strategized IP enforcement actions, involving Trademarks, Copyrights, Designs, Patents, Domain Names, Confidential information, Trade secret, Comparative advertising, Counterfeiting, Ambush Marketing and executed Anti-piracy operations in India and South Asia Subcontinent, before expanding his foray into commercial litigation, arbitration and dispute resolution practice.

Ashish has had exposures in sectors including Food & Drugs, Telecom, Infrastructure, Pharmaceutical, Information Technology, Media, Television and Broadcast, Foreign Investments, Defense. He continues to advise a wide range of industries on protection of their Intellectual Property Rights. He regularly advises on Food Laws and assists in compliance with various regulations under the FSSA, 2006 and D&C Act.

Ashish is adept in providing legal solutions in conflict situations – involving contractual disputes, government actions, regulatory changes, statutory violations. He regularly undertakes risk analysis and advices on key legal issues involved in commercial transactions with keen eye on resolution of potential conflict situations.

Ashish is currently representing clients before Arbitral tribunal(s), courts in seeking enforcement of domestic / foreign awards. Ashish has been involved in advising and representing clients before Tribunals like TDSAT, NCLT/NCLAT, DRT, High Courts, District Courts and the Supreme Court of India.

Ashish was a Partner at Lall & Sethi and Luthra & Luthra prior to joining ELP.


Legal 500

Recommended for Litigation and Arbitration
Recommended for Projects & Energy

RSG India Report

Ashish is described as ‘very hands on’ and ‘decisive’. He recommends a ‘firm plan of action’ with ‘innovative solutions’.

RSG India 2019 Report

Commended for his proactive and ‘detail-oriented’ advice. He was described as ‘highly commercial and practical’.

45th GST Council Meeting Highlights

18 Sep 2021 | Read More

What FDA full approval to Pfizer-Bio Ntech vax means

25 Aug 2021 | Read More

Union Budget 2021: An Analysis

2 Feb 2021 | Read More

Future of India’s dispute resolution

2 Feb 2021 | Read More

FAQ on Employment

2 Feb 2021 | Read More

Delhi HC’s VC Hearing Rules – Taking the Virtual Courts System Forward

2 Feb 2021 | Read More

A Pandemic of Notifications: Major Challenges During Lockdown

2 Feb 2021 | Read More

Telecom Sector’s intervention

2 Feb 2021 | Read More

India is staring at a medical-device crisis

2 Feb 2021 | Read More

ELP Knowledge Series – India Update Part 1 of 2019

19 Feb 2019 | Read More

Budget 2019: Judicial Reform Is What This Economy Needs Now

2 Feb 2019 | Read More

Interim Union Budget 2019 – An Analysis

1 Feb 2019 | Read More

Delhi HC stays ban on sale and manufacture of Oxytocin till October

31 Aug 2018 | Read More

WTO Dispute Settlement: Case Summaries (2017)

10 May 2018 | Read More

Can India PharmaInc find its lost Mojo

5 Jan 2018 | Read More

Supreme court ask drugs advisory body to decide fate over fate of over 334 banned combination medicines

15 Dec 2017 | Read More

Supreme court ask drugs advisory body to decide fate over fate of over 334banned combination medicines

15 Dec 2017 | Read More

Government need not consult statutory board to ban to ban combo drugs : Supreme Court

16 Nov 2017 | Read More

Easing license extension for drug makers, sellers

23 Jun 2017 | Read More

Easing licence extension for drug makers, sellers

23 Jun 2017 | Read More

Arbitration & Conciliation Act, 1996

15 Aug 1996 | Read More

The Changing Landscape of Arbitration in India

21 Sep 2021 | Read More